Polymer Reagent Linkage for Controlled Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering active agents like polypeptides face challenges due to short half-life, immune responses, and inactivation when conjugated with long polyethylene glycol chains, leading to inconvenient and frequent injections, and unpredictable in vivo degradation rates.
Innovation Solution
Development of polymeric reagents with a specific internal structural orientation, featuring a water-soluble polymer linked to a nitrogen atom and a reactive group, allowing for customized hydrolysis rates and improved conjugation with active agents, enhancing water solubility and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If long polyethylene glycol chains are used to conjugate with active agents, then water solubility is improved, but the active agent becomes substantially inactive due to the polymer chain wrapping around and blocking access to ligands
Solution Approach 1:
The invention divides the conjugate structure into distinct segments: a water-soluble polymer portion and a biologically active agent portion, connected through a specific carbamate or urea linkage. This segmentation allows the polymer to provide solubility while the active agent maintains its functionality by not being completely enveloped by the polymer chain.
Solution Approach 2:
The carbamate or urea linkage acts as an intermediary connection between the water-soluble polymer and the biologically active agent. This specific linkage structure provides a controlled interface that maintains the activity of the agent while enabling the solubility benefits of the polymer, preventing the polymer from completely wrapping around and blocking the agent.
2Duration of action of stationary object
If conventional conjugation methods are used to extend half-life, then immunogenicity is reduced, but the degradation rate becomes unpredictable and requires frequent injections
Solution Approach 1:
The invention changes the chemical parameters of the conjugate by specifically using carbamate or urea linkages with defined hydrolysis rates. This allows control over the degradation kinetics, extending the half-life to a predictable range that reduces dosing frequency while maintaining therapeutic efficacy.
Solution Approach 2:
The conjugate structure is designed with dynamic degradation characteristics through the carbamate/urea linkage, which hydrolyzes at a controlled rate in vivo. This dynamic property allows the conjugate to maintain extended half-life initially, then gradually degrade to release the active agent, optimizing both half-life extension and dosing convenience.
3Object-affected harmful factors
If polyethylene glycol is conjugated to active agents, then immunogenicity is reduced, but the conjugate structure lacks customizable degradation rates
Solution Approach 1:
The invention modifies the chemical parameters of the conjugate linkage to specifically use carbamate or urea structures, which have predictable and customizable hydrolysis rates. This provides versatility in controlling degradation kinetics while maintaining the low immunogenicity benefits of polyethylene glycol conjugation.
Solution Approach 2:
The invention creates a composite conjugate structure combining polyethylene glycol (for low immunogenicity) with specific carbamate or urea linkage moieties (for controlled degradation). This composite approach integrates the beneficial properties of both components: the polymer provides immunoprotection while the specific linkage provides predictable, customizable degradation kinetics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides active agent-polymer conjugates with extended half-life, reduced immunogenicity, and customizable degradation rates, leading to less frequent injections and improved therapeutic efficacy.
Implementation Method 1
The internal structural orientation of the carbamate or urea moiety provides a predictable rate of hydrolysis.
Data Source
AI summary
Polymeric reagents are provided comprising a moiety of atoms arranged in a specific order, wherein the moiety is positioned between a water-soluble polymer and a reactive group. The polymeric reagents are useful for, among other things, forming polymer-active agent conjugates. Related methods, compositions, preparations, and so forth are also provided.